Evidence for interictal blood-brain barrier dysfunction in people with epilepsy.
contrast-enhanced MRI
neuropsychology
presurgical evaluation
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
04 Mar 2024
04 Mar 2024
Historique:
revised:
11
02
2024
received:
08
10
2023
accepted:
12
02
2024
medline:
4
3
2024
pubmed:
4
3
2024
entrez:
4
3
2024
Statut:
aheadofprint
Résumé
Interictal blood-brain barrier dysfunction in chronic epilepsy has been demonstrated in animal models and pathological specimens. Ictal blood-brain barrier dysfunction has been shown in humans in vivo using an experimental quantitative magnetic resonance imaging (MRI) protocol. Here, we hypothesized that interictal blood-brain barrier dysfunction is also present in people with drug-resistant epilepsy. Thirty-nine people (21 females, mean age at MRI ± SD = 30 ± 8 years) with drug-resistant epilepsy were prospectively recruited and underwent interictal T1-relaxometry before and after administration of a paramagnetic contrast agent. Likewise, quantitative T1 was acquired in 29 people without epilepsy (12 females, age at MRI = 48 ± 18 years). Quantitative T1 difference maps were calculated and served as a surrogate imaging marker for blood-brain barrier dysfunction. Values of quantitative T1 difference maps inside hemispheres ipsilateral to the presumed seizure onset zone were then compared, on a voxelwise level and within presumed seizure onset zones, to the contralateral side of people with epilepsy and to people without epilepsy. Compared to the contralateral side, ipsilateral T1 difference values were significantly higher in white matter (corrected p < .05), gray matter (uncorrected p < .05), and presumed seizure onset zones (p = .04) in people with epilepsy. Compared to people without epilepsy, significantly higher T1 difference values were found in the anatomical vicinity of presumed seizure onset zones (p = .004). A subgroup of people with hippocampal sclerosis demonstrated significantly higher T1 difference values in the ipsilateral hippocampus and in regions strongly interconnected with the hippocampus compared to people without epilepsy (corrected p < .01). Finally, z-scores reflecting the deviation of T1 difference values within the presumed seizure onset zone were associated with verbal memory performance (p = .02) in people with temporal lobe epilepsy. Our results indicate a blood-brain barrier dysfunction in drug-resistant epilepsy that is detectable interictally in vivo, anatomically related to the presumed seizure onset zone, and associated with cognitive deficits.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV. Blood-brain barrier: from physiology to disease and Back. Physiol Rev. 2019;99(1):21-78.
Liebner S, Dijkhuizen RM, Reiss Y, Plate KH, Agalliu D, Constantin G. Functional morphology of the blood-brain barrier in health and disease. Acta Neuropathol. 2018;135(3):311-336.
Jasper HH. Physiopathological mechanisms of post-traumatic epilepsy. Epilepsia. 1970;11(1):73-80.
Friedman A. Blood-brain barrier dysfunction, status epilepticus, seizures, and epilepsy: a puzzle of a chicken and egg? Epilepsia. 2011;52:19-20.
Löscher W, Friedman A. Structural, molecular, and functional alterations of the blood-brain barrier during Epileptogenesis and epilepsy: a cause, consequence, or both? IJMS. 2020;21(2):591.
Vazana U, Veksler R, Pell GS, Prager O, Fassler M, Chassidim Y, et al. Glutamate-mediated blood-brain barrier opening: implications for neuroprotection and drug delivery. J Neurosci. 2016;36(29):7727-7739.
Bar-Klein G, Lublinsky S, Kamintsky L, Noyman I, Veksler R, Dalipaj H, et al. Imaging blood-brain barrier dysfunction as a biomarker for epileptogenesis. Brain. 2017;140(6):1692-1705.
Nitsch C, Klatzo I. Regional patterns of blood-brain barrier breakdown during epileptiform seizures induced by various convulsive agents. J Neurol Sci. 1983;59(3):305-322.
Boux F, Forbes F, Collomb N, Zub E, Mazière L, Bock F, et al. Neurovascular multiparametric MRI defines epileptogenic and seizure propagation regions in experimental mesiotemporal lobe epilepsy. Epilepsia. 2021;62(5):1244-1255.
Breuer H, Meier M, Schneefeld S, Härtig W, Wittneben A, Märkel M, et al. Multimodality imaging of blood-brain barrier impairment during epileptogenesis. J Cereb Blood Flow Metab. 2017;37(6):2049-2061.
Hanael E, Veksler R, Friedman A, Bar-Klein G, Senatorov VV, Kaufer D, et al. Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging. Epilepsia. 2019;60(5):1005-1016.
Hanael E, Baruch S, Chai O, Nir Z, Rapoport K, Ruggeri M, et al. Detection of blood-brain barrier dysfunction using advanced imaging methods to predict seizures in dogs with meningoencephalitis of unknown origin. J Vet Intern Med. 2022;36(2):702-712.
Mendes NF, Pansani AP, Carmanhães ERF, Tange P, Meireles JV, Ochikubo M, et al. The blood-brain barrier breakdown during acute phase of the pilocarpine model of epilepsy is dynamic and time-dependent. Front Neurol. 2019;10:382.
van Vliet EA, Otte WM, Gorter JA, Dijkhuizen RM, Wadman WJ. Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study. Neurobiol Dis. 2014;63:74-84.
van Vliet EA, Ndode-Ekane XE, Lehto LJ, Gorter JA, Andrade P, Aronica E, et al. Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury. Neurobiol Dis. 2020;145:105080.
Tomkins O, Shelef I, Kaizerman I, Eliushin A, Afawi Z, Misk A, et al. Blood-brain barrier disruption in post-traumatic epilepsy. J Neurol Neurosurg Psychiatry. 2008;79(7):774-777.
Tomkins O, Feintuch A, Benifla M, Cohen A, Friedman A, Shelef I. Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. Cardiovasc Psychiatry Neurol. 2011;2011:1-11.
Rüber T, David B, Lüchters G, Nass RD, Friedman A, Surges R, et al. Evidence for peri-ictal blood-brain barrier dysfunction in patients with epilepsy. Brain. 2018;141(10):2952-2965.
Greene C, Hanley N, Reschke CR, Reddy A, Mäe MA, Connolly R, et al. Microvascular stabilization via blood-brain barrier regulation prevents seizure activity. Nat Commun. 2022;13(1):2003.
Reiss Y, Bauer S, David B, Devraj K, Fidan E, Hattingen E, et al. The neurovasculature as a target in temporal lobe epilepsy. Brain Pathol. 2023;33(2):e13147.
Rigau V, Morin M, Rousset M-C, de Bock F, Lebrun A, Coubes P, et al. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007;130(7):1942-1956.
van Vliet EA, da Costa AS, Redeker S, van Schaik R, Aronica E, Gorter JA. Blood-brain barrier leakage may lead to progression of temporal lobe epilepsy. Brain. 2007;130(2):521-534.
Raabe A, Schmitz AK, Pernhorst K, Grote A, von der Brelie C, Urbach H, et al. Cliniconeuropathologic correlations show astroglial albumin storage as a common factor in epileptogenic vascular lesions: albumin in vascular lesions. Epilepsia. 2012;53(3):539-548.
Liu JYW, Thom M, Catarino CB, Martinian L, Figarella-Branger D, Bartolomei F, et al. Neuropathology of the blood-brain barrier and pharmaco-resistance in human epilepsy. Brain. 2012;135(10):3115-3133.
Han H, Mann A, Ekstein D, Eyal S. Breaking bad: the structure and function of the blood-brain barrier in epilepsy. AAPS J. 2017;19(4):973-988.
Chassidim Y, Veksler R, Lublinsky S, Pell GS, Friedman A, Shelef I. Quantitative imaging assessment of blood-brain barrier permeability in humans. Fluids Barriers CNS. 2013;10(1):9.
Elschot EP, Backes WH, Postma AA, Van Oostenbrugge RJ, Staals J, Rouhl RPW, et al. A comprehensive view on MRI techniques for imaging blood-brain barrier integrity. Invest Radiol. 2021;56(1):10-19.
Hattingen E, Jurcoane A, Daneshvar K, Pilatus U, Mittelbronn M, Steinbach JP, et al. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. Neuro Oncol. 2013;15(10):1395-1404.
Nöth U, Tichy J, Tritt S, Bähr O, Deichmann R, Hattingen E. Quantitative T1 mapping indicates tumor infiltration beyond the enhancing part of glioblastomas. NMR Biomed [Internet]. 2020 [cited 2023];33(3):e4242. https://doi.org/10.1002/nbm.4242
Blystad I, Warntjes JBM, Smedby Ö, Lundberg P, Larsson E-M, Tisell A. Quantitative MRI using relaxometry in malignant gliomas detects contrast enhancement in peritumoral oedema. Sci Rep. 2020;10(1):17986.
Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies: definition of drug resistant epilepsy. Epilepsia. 2009;51(6):1069-1077.
Smith-Cohn MA, Burley NB, Grossman SA. Transient opening of the blood-brain barrier by vasoactive peptides toIncrease CNS drug delivery: reality versus wishful thinking? Curr Neuropharmacol. 2022;20(7):1383-1399.
Helmstaedter C, Witt J-A. Anti-convulsant drugs and cognition. In: Riederer P, Laux G, Nagatsu T, Le W, Riederer C, editors. NeuroPsychopharmacotherapy [Internet]. Cham: Springer International Publishing; 2022 [cited 2023]. p. 3517-3527. https://doi.org/10.1007/978-3-030-62059-2_375
Preibisch C, Deichmann R. Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles: influence of RF spoiling on T1 mapping. Magn Reson Med. 2009;61(1):125-135.
Venkatesan R, Lin W, Haacke EM. Accurate determination of spin-density andT1 in the presence of RF-field inhomogeneities and flip-angle miscalibration. Magn Reson Med. 1998;40(4):592-602.
Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TEJ, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208-S219.
Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17(3):143-155.
Zhang Y, Brady M, Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001;20(1):45-57.
Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17(2):825-841.
Lavini C, Verhoeff JJC. Reproducibility of the gadolinium concentration measurements and of the fitting parameters of the vascular input function in the superior sagittal sinus in a patient population. Magn Reson Imaging. 2010;28(10):1420-1430.
Avants BB, Tustison NJ, Song G, Cook PA, Klein A, Gee JC. A reproducible evaluation of ANTs similarity metric performance in brain image registration. Neuroimage. 2011;54(3):2033-2044.
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487-1505.
Helmstaedter C, Durwen HF. VLMT: Verbaler Lern- und Merkfähigkeitstest: Ein praktikables und differenziertes Instrumentarium zur Prüfung der verbalen Gedächtnisleistungen [VLMT: A useful tool to assess and differentiate verbal memory performance]. Schweizer Archiv für Neurologie, Neurochirurgie und Psychiatrie. Zurich, Switzerland: Art Institute Orell Fussli; 1990. p. 21-30.
Winkler AM, Ridgway GR, Webster MA, Smith SM, Nichols TE. Permutation inference for the general linear model. Neuroimage. 2014;92:381-397.
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
Maller JJ, Welton T, Middione M, Callaghan FM, Rosenfeld JV, Grieve SM. Revealing the hippocampal connectome through super-resolution 1150-direction diffusion MRI. Sci Rep. 2019;9(1):2418.
Villringer K, Sanz Cuesta BE, Ostwaldt A-C, Grittner U, Brunecker P, Khalil AA, et al. DCE-MRI blood-brain barrier assessment in acute ischemic stroke. Neurology. 2017;88(5):433-440.
Sulimai N, Brown J, Lominadze D. Vascular effects on cerebrovascular permeability and neurodegeneration. Biomolecules. 2023;13(4):648.
Verheggen ICM, de Jong JJA, van Boxtel MPJ, Postma AA, Jansen JFA, Verhey FRJ, et al. Imaging the role of blood-brain barrier disruption in normal cognitive ageing. GeroScience. 2020;42(6):1751-1764.
Wardlaw JM, Makin SJ, Valdés Hernández MC, Armitage PA, Heye AK, Chappell FM, et al. Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study. Alzheimers Dement. 2017;13(6):634-643.
Li M, Li Y, Zuo L, Hu W, Jiang T. Increase of blood-brain barrier leakage is related to cognitive decline in vascular mild cognitive impairment. BMC Neurol. 2021;21(1):159.
van de Haar HJ, Burgmans S, Jansen JFA, van Osch MJP, van Buchem MA, Muller M, et al. Blood-brain barrier leakage in patients with early Alzheimer disease. Radiology. 2016;281(2):527-535.
Saling MM. Verbal memory in mesial temporal lobe epilepsy: beyond material specificity. Brain. 2009;132(3):570-582.
Bach M, Laun FB, Leemans A, Tax CMW, Biessels GJ, Stieltjes B, et al. Methodological considerations on tract-based spatial statistics (TBSS). Neuroimage. 2014;100:358-369.
Erdő F, Denes L, De Lange E. Age-associated physiological and pathological changes at the blood-brain barrier: a review. J Cereb Blood Flow Metab. 2017;37(1):4-24.